Certara Due Diligence/Asset Evaluation

Certara Due Diligence/Asset Evaluation

Integrated Asset Evaluation for Go/No Go Drug Investment Decisions Partnering and acquisition of drug product candidates is an essential part of the pharmaceutical business ecosystem. While emerging companies are focused on drug discovery and early development, they often do not have the funding or experience to manage the complex, expensive, and time consuming path to […]

Read More
Topics:
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog